Schedule M/U Record-Keeping Breaches as Chapter IV Contraventions: Attracting Section 18(a)(vi)/27(d), Three-Year Limitation, and Sessions Trial under Section 32(2)

1. Introduction

M/s SBS Biotech & Others v. State of Himachal Pradesh (2026 INSC 171, decided on 20-02-2026) arose from regulatory inspections under the Drugs and Cosmetics Act, 1940 (“the Act”) and the Drugs and Cosmetics Rules, 1945 (“the Rules”). The appellants—(i) M/s SBS Biotech (a licensed manufacturer), (ii) its Production Head, and (iii) an alleged managing partner—faced prosecution following an inspection (22.07.2014) and re-inspection (05.08.2014) alleging serious deficiencies in maintenance/production of manufacturing and distribution records concerning a controlled/habit-forming drug input, Pseudoephedrine, and associated batch production records.

The key legal issues were:

  • Classification of alleged misconduct: whether non-maintenance/non-production and alleged manipulation of records required by Schedule M and Schedule U constitutes an offence under Section 18(a)(vi) read with Rule 74 punishable under Section 27(d), or is confined to Section 18-B punishable under Section 28-A.
  • Limitation: whether the complaint (filed 27.02.2017) was barred under Section 468 Cr.P.C., depending on the applicable punishment provision (and hence limitation period).
  • Forum/jurisdiction: whether, given Sections 32(2), 36-A and 36AB of the Act, such offences should be tried summarily by a JMFC or by a Sessions Court/Special Judge.
  • Effect of omission in the cognizance order: whether non-mention of Section 27(d) in the body of the cognizance order was fatal or merely clerical.

2. Summary of the Judgment

The Supreme Court dismissed the appeal and upheld the High Court’s refusal to quash the complaint. It held, in substance, that:

  • The allegations concerning failure to maintain/produce records under Schedule M and Schedule U, coupled with alleged tampering/manipulation and discrepancies, are capable of constituting a contravention of Section 18(a)(vi) (contravention of Chapter IV / rules) and therefore attract punishment under Section 27(d).
  • Since Section 27(d) prescribes imprisonment up to two years, the applicable limitation under Section 468 Cr.P.C. is three years; the complaint filed within about two years and six months was therefore within time.
  • Section 32(2) (no court inferior to Sessions shall try Chapter IV offences, “save as otherwise provided”) governed; Section 36-A was held inapplicable on these facts. Committal to the Sessions/Special Judge was not illegal.
  • The missing reference to Section 27(d) in the handwritten cognizance order was treated as a non-fatal omission/clerical slip, especially since Section 27(d) appeared in the complaint title and related orders and the case was committed on that footing.

3. Analysis

3.1 Precedents Cited

(a) Miteshbhai J. Patel Vs. Drug Inspector, 2025 SCC online SC 2203

The appellants relied on this decision to argue limitation. The Supreme Court distinguished it on facts:

  • In Miteshbhai J. Patel Vs. Drug Inspector, 2025 SCC online SC 2203, the Court reiterated that complaints disclosing offences punishable under Section 27 must be filed within three years, but quashing followed because the complaints there were filed beyond three years.
  • Here, since the complaint was filed within three years, the precedent did not assist the appellants.

(b) Cheminova (India) Ltd. Vs. State of Punjab reported in 2021 (8) SCC 818

This was also cited on limitation. The Court again distinguished it:

  • In Cheminova (India) Ltd. Vs. State of Punjab reported in 2021 (8) SCC 818, the complaint was filed beyond three years and was quashed as barred by limitation (the judgment text references limitation principles in the Cr.P.C.).
  • In SBS Biotech, the prosecution was initiated within three years; hence no bar arose.

(c) Union of India v. Ashok Kumar Sharma reported in 2021 (12) SCC 674

The appellants argued the High Court wrongly relied on this decision as it arose in a different context. The Supreme Court did not build its ratio upon Union of India v. Ashok Kumar Sharma reported in 2021 (12) SCC 674; instead, it resolved the matter primarily through statutory interpretation of the Act and the Rules, and by distinguishing the limitation precedents above. Practically, the judgment signals that where the statute’s forum and limitation consequences are clear from the charging provisions, ancillary reliance on unrelated context precedents does not alter outcome.

3.2 Legal Reasoning

(i) Record-keeping under Schedule M/U can engage Section 18(a)(vi) and Section 27(d)

The Court treated the alleged failures (and alleged manipulation) in manufacturing documentation as more than a standalone “information-furnishing” default. It reasoned:

  • Section 18(a)(vi) prohibits manufacturing/sale/distribution etc. of any drug “in contravention of any of the provisions of [Chapter IV] or any rule made thereunder.”
  • Rule 74 (particularly clause (d), as highlighted) requires maintenance/retention of manufacturing records with particulars in Schedule U.
  • Schedule M (GMP requirements) and Schedule U (manufacturing record particulars) operationalize compliance duties; deficiencies in such mandated documentation were treated as capable of amounting to “contravention of rules made under Chapter IV,” thus triggering Section 18(a)(vi).
  • Where Section 18(a)(vi) is invoked, punishment tracks to Section 27(d) (for “any drug… in contravention of any other provision of this Chapter or any rule made thereunder”).

In effect, the Court accepted that mandated manufacturing documentation (especially batch production/consumption/distribution traceability) is integral to lawful “manufacture for sale/distribution” under the Chapter IV regime, not merely an ancillary paperwork requirement.

(ii) Limitation: choosing the correct penal provision determines the period

The appellants sought to recharacterize the prosecution as only under Section 18-B/Section 28-A (maximum one year), which would reduce limitation to one year under Section 468 Cr.P.C. The Court rejected this by holding that the complaint disclosed Section 18(a)(vi) attracting Section 27(d) (up to two years), making the limitation three years.

Importantly, the Court relied on the overall complaint allegations (including discrepancies, alleged tampering, inability to account for inputs/outputs) to justify the charging under Section 18(a)(vi)/27(d), rather than treating the matter as a pure Section 18-B default.

(iii) Cognizance/clerical omission: substance over form

The appellants argued the Magistrate took cognizance only for Section 28-A type offences and that the High Court wrongly treated omission of Section 27(d) as typographical. The Supreme Court examined the complaint title, cognizance order heading, and committal order, and concluded that the omission in the handwritten portion was a “missed” mention, not a jurisdictional defect undermining proceedings. The committal order explicitly proceeded on Section 27(d) read with Section 28-A.

(iv) Forum: Section 32(2) prevails; Section 36-A held inapplicable

On trial forum, the Court emphasized:

  • Section 32(2): “Save as otherwise provided,” no court inferior to Sessions shall try an offence punishable under Chapter IV.
  • Section 36-A: provides summary trial by JMFC for offences punishable up to three years, but excludes offences triable by the Special Court under Section 36AB or Court of Session under the Act.

The Court reasoned that because Section 32(2) directs Chapter IV offences to Sessions (unless otherwise provided), Section 36-A could not be used to pull such offences down to the Magistrate level on these facts. Therefore, committal to the Sessions/Special Judge was upheld.

3.3 Impact

  • Prosecutorial charging latitude for GMP/documentation lapses: The decision supports the proposition that serious failures in mandated manufacturing documentation under Rule 74, Schedule M, and Schedule U can be prosecuted as a Chapter IV contravention under Section 18(a)(vi), attracting Section 27(d), rather than being confined to Section 18-B/28-A.
  • Limitation consequences: By affirming Section 27(d) applicability, the Court effectively confirms a three-year limitation window (via Cr.P.C. limitation rules) for similarly framed complaints, reducing the success of “one-year limitation” defences where the complaint pleads a Chapter IV/rules contravention.
  • Trial forum clarity in Chapter IV matters: The judgment reinforces that Section 32(2) is a strong jurisdictional anchor for Chapter IV offences, and litigants should not assume Section 36-A automatically routes all ≤3-year offences to summary trial before a JMFC.
  • Procedural objections to drafting slips: Courts may treat omissions in the body of cognizance orders as curable/clerical when the record consistently indicates the intended offence and forum—limiting quashing attempts based purely on form.

4. Complex Concepts Simplified

  • Section 18(a)(vi): A broad prohibition—if you manufacture/sell/distribute a drug while violating Chapter IV requirements or any rule under it, you breach this provision.
  • Schedule M (GMP): Operational standards for manufacturing quality systems (premises, processes, documentation). Non-compliance can indicate that manufacturing is not being done as legally required.
  • Schedule U: The detailed “what must be written down” list in manufacturing records (e.g., raw materials, batch details). It enables traceability and regulatory verification.
  • Rule 74(d): A rule that specifically requires batch-wise manufacturing records (as per Schedule U) and retention for a defined period.
  • Section 18-B vs. Section 18(a)(vi): Section 18-B is specifically about keeping records and furnishing information; Section 18(a)(vi) is broader and can capture rule-contraventions connected to lawful manufacture/sale. This case treats major Schedule M/U documentation failures as fitting within the broader Chapter IV/rules contravention route.
  • Limitation under Section 468 Cr.P.C.: The time limit to file/take cognizance depends on maximum punishment. If the offence is treated as up to two years (Section 27(d)), the time window is longer than if it is treated as up to one year (Section 28-A).
  • Section 32(2) “save as otherwise provided”: A default rule that Chapter IV offences go to Sessions-level courts unless the Act clearly carves out an exception.

5. Conclusion

SBS Biotech is significant for linking mandated GMP and manufacturing-record obligations (Schedules M and U read with Rule 74) to the broader “contravention of Chapter IV/rules” framework under Section 18(a)(vi), thereby permitting punishment under Section 27(d) and applying a three-year limitation approach rather than a one-year limitation premised on Section 28-A alone. It also strengthens the jurisdictional proposition that, absent a clear statutory exception, Chapter IV offences are to be tried by courts not inferior to Sessions under Section 32(2), limiting reliance on Section 36-A to insist on Magistrate-level summary trial.